$SLNO
SOLENO THERAPEUTICS INC

2019 Q1 Form 10-K Financial Statement

#000156459019008508 Filed on March 20, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q2
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.010M $1.370M $1.770M
YoY Change 7.49% -18.45% -19.36%
% of Gross Profit
Research & Development $2.760M $2.190M $1.714M
YoY Change 133.9% 114.71% 121.73%
% of Gross Profit
Depreciation & Amortization $490.0K $490.0K $490.0K
YoY Change 0.0% -15.52% 16.67%
% of Gross Profit
Operating Expenses $4.978M $3.560M $3.413M
YoY Change 43.25% 31.37% 14.99%
Operating Profit -$4.978M -$3.413M
YoY Change 43.25% 14.99%
Interest Expense -$190.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.052M $1.930M -$3.222M
YoY Change -1209.19% -396.92% 3561.36%
Pretax Income -$7.030M $390.0K -$6.640M
YoY Change 113.68% -106.67% 116.99%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$7.030M $260.0K -$7.058M
YoY Change 84.81% -105.49% 77.83%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$221.3K $11.52K -$346.9K
COMMON SHARES
Basic Shares Outstanding 31.76M 21.44M shares 19.77M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.19M $24.08M $12.59M
YoY Change 35.78% 40.82% 66.75%
Cash & Equivalents $19.40M $23.10M $12.59M
Short-Term Investments $790.0K $980.0K
Other Short-Term Assets $600.0K $530.0K $720.0K
YoY Change -36.17% -40.45% -72.41%
Inventory $0.00
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $20.87M $24.67M $13.31M
YoY Change 31.99% 37.1% 29.01%
LONG-TERM ASSETS
Property, Plant & Equipment $19.00K $12.00K $13.00K
YoY Change 11.76% -47.83% -75.47%
Goodwill
YoY Change
Intangibles $17.98M $18.47M $19.44M
YoY Change -9.76% -9.52%
Long-Term Investments
YoY Change
Other Assets $0.00 $126.0K
YoY Change -100.0% 0.0%
Total Long-Term Assets $18.00M $18.48M $20.03M
YoY Change -12.28% -12.11% -0.15%
TOTAL ASSETS
Total Short-Term Assets $20.87M $24.67M $13.31M
Total Long-Term Assets $18.00M $18.48M $20.03M
Total Assets $38.87M $43.15M $33.34M
YoY Change 6.98% 10.58% 9.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.258M $934.0K $981.0K
YoY Change 11.03% 47.55% -4.66%
Accrued Expenses $990.0K $940.0K $860.0K
YoY Change 37.5% -3.09% -2.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.250M $1.877M $1.945M
YoY Change 15.86% 8.31% -8.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.99M $10.86M $13.00K
YoY Change 99823.08% 83438.46% -98.85%
Total Long-Term Liabilities $12.99M $10.86M $13.00K
YoY Change 99823.08% 83438.46% -98.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.250M $1.877M $1.945M
Total Long-Term Liabilities $12.99M $10.86M $13.00K
Total Liabilities $15.24M $12.74M $16.70M
YoY Change 16.49% 4.37% 352.07%
SHAREHOLDERS EQUITY
Retained Earnings -$134.1M -$127.0M -$124.6M
YoY Change 14.09% 11.73% 18.44%
Common Stock $157.7M $157.4M $141.2M
YoY Change 12.04% 12.05% 7.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.63M $30.41M $16.65M
YoY Change
Total Liabilities & Shareholders Equity $38.87M $43.15M $33.34M
YoY Change 6.98% 10.58% 9.75%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q2
OPERATING ACTIVITIES
Net Income -$7.030M $260.0K -$7.058M
YoY Change 84.81% -105.49% 77.83%
Depreciation, Depletion And Amortization $490.0K $490.0K $490.0K
YoY Change 0.0% -15.52% 16.67%
Cash From Operating Activities -$3.687M -$3.730M -$2.750M
YoY Change 46.31% 36.63% -8.33%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$170.0K
YoY Change -170.83%
Cash From Investing Activities -$10.00K -$170.0K $0.00
YoY Change -170.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 16.30M 540.0K
YoY Change -100.0% 16.93%
NET CHANGE
Cash From Operating Activities -3.687M -3.730M -2.750M
Cash From Investing Activities -10.00K -170.0K 0.000
Cash From Financing Activities 0.000 16.30M 540.0K
Net Change In Cash -3.697M 12.40M -2.210M
YoY Change 65.64% 8.3% -26.33%
FREE CASH FLOW
Cash From Operating Activities -$3.687M -$3.730M -$2.750M
Capital Expenditures $10.00K $0.00 $0.00
Free Cash Flow -$3.697M -$3.730M -$2.750M
YoY Change 36.63% -8.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001484565
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Entity Registrant Name
EntityRegistrantName
SOLENO THERAPEUTICS INC
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
64000
CY2018Q4 slno Minority Interest Investment In Subsidiary
MinorityInterestInvestmentInSubsidiary
978000
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31755169
CY2018Q2 dei Entity Public Float
EntityPublicFloat
27600000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23099000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17100000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
529000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
343000
CY2017Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
516000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
24670000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
17994000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126000
CY2018 dei Trading Symbol
TradingSymbol
SLNO
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19238972
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19238972
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31755169
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31755169
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3069000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-14301000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6556000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7178000
CY2017 slno Asset Acquisition Contingent Consideration Change In Fair Value
AssetAcquisitionContingentConsiderationChangeInFairValue
2492000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15385000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6584000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.71
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8977795
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
140495000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113697000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
26817000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39022000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5964000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23099000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-590000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18469000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20413000
CY2017Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
466000
CY2018Q4 us-gaap Assets
Assets
43151000
CY2017Q4 us-gaap Assets
Assets
39022000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
934000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
633000
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
943000
CY2017Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
973000
CY2017Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
127000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1877000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1733000
CY2018Q4 slno Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
5649000
CY2017Q4 slno Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
5082000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13000
CY2017Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
225000
CY2018Q4 us-gaap Liabilities
Liabilities
12738000
CY2017Q4 us-gaap Liabilities
Liabilities
12205000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
32000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
157413000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127032000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
30413000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43151000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26000
CY2018 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6000
CY2017 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
4000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-522000
CY2018 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
1994000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2460000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1271000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11841000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13442000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1650000
CY2018 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11841000
CY2017 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11792000
CY2018 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-1494000
CY2017 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-3399000
CY2017 slno Disposal Group Including Discontinued Operation Income Expenses
DisposalGroupIncludingDiscontinuedOperationIncomeExpenses
-194000
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1494000
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3593000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-13335000
CY2018 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.56
CY2017 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.31
CY2018 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.07
CY2017 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.40
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20975479
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3435000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1000000
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
278000
CY2018 slno Warrants Issued In Connection With Sale Of Common Stock
WarrantsIssuedInConnectionWithSaleOfCommonStock
582000
CY2017 slno Warrants Issued In Connection With Sale Of Common Stock
WarrantsIssuedInConnectionWithSaleOfCommonStock
4187000
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
602000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
829000
CY2018 slno Issuance Of Restricted Common Stock For Bonuses Value
IssuanceOfRestrictedCommonStockForBonusesValue
159000
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
275000
CY2018 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
250000
CY2017 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1172000
CY2018 us-gaap Profit Loss
ProfitLoss
-13335000
CY2017 us-gaap Profit Loss
ProfitLoss
-15385000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1963000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1611000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
988000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
880000
CY2017 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1651000
CY2018 us-gaap Other Noncash Expense
OtherNoncashExpense
275000
CY2017 us-gaap Other Noncash Expense
OtherNoncashExpense
278000
CY2017 slno Noncash Expense On Shares Issued
NoncashExpenseOnSharesIssued
602000
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-160000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
97000
CY2018 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
64000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
249000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
191000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-43000
CY2017 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-78000
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-40000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10322000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6919000
CY2018 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1361000
CY2017 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3031000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11683000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9950000
CY2017 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
573000
CY2017 slno Proceeds From Security Deposit On Sublease
ProceedsFromSecurityDepositOnSublease
13000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-8000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-562000
CY2018 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-172000
CY2017 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
716000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-180000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
154000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000
CY2018 slno Proceeds From Sale Of Common Stock And Common Stock Warrants
ProceedsFromSaleOfCommonStockAndCommonStockWarrants
16500000
CY2017 slno Proceeds From Sale Of Common Stock And Common Stock Warrants
ProceedsFromSaleOfCommonStockAndCommonStockWarrants
15008000
CY2018 slno Cash Paid For The Issuance Of Common Stock And Common Stock Warrants
CashPaidForTheIssuanceOfCommonStockAndCommonStockWarrants
198000
CY2017 slno Cash Paid For The Issuance Of Common Stock And Common Stock Warrants
CashPaidForTheIssuanceOfCommonStockAndCommonStockWarrants
1063000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16302000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
23945000
CY2018 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
1525000
CY2017 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
225000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17827000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24170000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14374000
CY2017 us-gaap Stock Issued1
StockIssued1
17246000
CY2017 slno Noncash Or Part Noncash Acquisition Contingent Consideration
NoncashOrPartNoncashAcquisitionContingentConsideration
2590000
CY2018 slno Accrued Liability For Cost Of Issuing Common Stock
AccruedLiabilityForCostOfIssuingCommonStock
52000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those estimates. Key estimates included in the financial statements include the valuation of deferred income tax assets, the valuation of financial instruments, stock-based compensation, value and life of acquired intangibles, and the valuation of contingent liabilities for the purchase price of assets obtained through acquisition. </p>
CY2018 slno Second Commercial Sales Milestone
SecondCommercialSalesMilestone
200000000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents at one U.S. commercial bank that management believes is of high credit quality. Cash and cash equivalents deposited with these commercial banks exceeded the Federal Deposit Insurance Corporation insurable limit at December&#160;31, 2018 and 2017. The Company expects the maintenance of balances in excess of insurable limits will continue. </p>
CY2017Q1 slno Contingent Liability Payment On Achievement Of Sales Milestone
ContingentLiabilityPaymentOnAchievementOfSalesMilestone
2600000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.028
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2018Q1 us-gaap Liabilities
Liabilities
13079000
CY2018Q2 us-gaap Liabilities
Liabilities
16695000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117501000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124559000
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-163000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3255000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3092000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
185000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3222000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3037000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.022
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2017Q4 slno Contingent Liability Payment On Achievement Of Sales Milestone
ContingentLiabilityPaymentOnAchievementOfSalesMilestone
5100000
CY2017Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
213000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
177000
CY2018Q4 slno Working Capital
WorkingCapital
22800000
CY2018Q4 slno Concentration Risk Credit Risk Numberof Banks
ConcentrationRiskCreditRiskNumberofBanks
1
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q4 us-gaap Inventory Net
InventoryNet
0
CY2010Q2 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
450000
CY2010Q2 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
8000
CY2018 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22003000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3534000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18469000
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1900000
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1700000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
105000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
97000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74000
CY2018 us-gaap Depreciation
Depreciation
19000
CY2017 us-gaap Depreciation
Depreciation
44000
CY2015Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P4Y
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8171
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23000
CY2015Q3 slno Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P3Y
CY2016Q1 slno Additional Operating Lease Office Space
AdditionalOperatingLeaseOfficeSpace
5265
CY2015Q3 slno Lease Expiration Period
LeaseExpirationPeriod
2019-08
CY2015Q3 slno Sublease Expiration Period
SubleaseExpirationPeriod
2019-08
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22000
CY2015Q1 slno Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P2Y
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
344000
CY2018Q4 slno Operating Leases Future Minimum Payments Due In Two Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInTwoYearsAndThereafter
0
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
323000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
514000
CY2017Q1 us-gaap Share Price
SharePrice
3.85
CY2018 slno Asset Acquisition Fair Value Of Stock Consideration
AssetAcquisitionFairValueOfStockConsideration
4200000
CY2018 slno Asset Acquisition Fair Value Of Cash Consideration
AssetAcquisitionFairValueOfCashConsideration
1100000
CY2018 slno Asset Acquisition Consideration Transferred1
AssetAcquisitionConsiderationTransferred1
5300000
CY2018 slno First Commercial Sales Milestone
FirstCommercialSalesMilestone
100000000
CY2018Q4 slno Contingent Liability Payment On Achievement Of Sales Milestone
ContingentLiabilityPaymentOnAchievementOfSalesMilestone
5600000
CY2018Q4 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
2000000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
988000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.027
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.019
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.61
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.71
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.69
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.08
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.88
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1200000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
71000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-11830000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13707000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-11000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-17000
CY2018 slno Income Tax Reconciliation Change In Net Operating Loss
IncomeTaxReconciliationChangeInNetOperatingLoss
590000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11841000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13724000
CY2018 slno Income Tax Reconciliation Change In Temporary Difference
IncomeTaxReconciliationChangeInTemporaryDifference
456000
CY2018 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-1494000
CY2017 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-3593000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
52000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
145000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
27678000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1578000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-73000
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1651000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2486000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4666000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-187000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-67000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
10613000
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4143000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-8485000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
99000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
121000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
143000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
295000
CY2018 slno Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-110000
CY2017 slno Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
343000
CY2018 slno Income Tax Reconciliation Change In Fair Value Of Contingent Consideration
IncomeTaxReconciliationChangeInFairValueOfContingentConsideration
119000
CY2018 slno Income Tax Rate Reconciliation Gain Loss On Deconsolidation Amount
IncomeTaxRateReconciliationGainLossOnDeconsolidationAmount
4000
CY2018 slno Income Tax Rate Reconciliation Disallowance Of Loss On Discontinued Operations Amount
IncomeTaxRateReconciliationDisallowanceOfLossOnDiscontinuedOperationsAmount
-426000
CY2017 slno Income Tax Reconciliation Acquisition Costs
IncomeTaxReconciliationAcquisitionCosts
203000
CY2017 us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
-677000
CY2018 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-49000
CY2017 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
909000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28532000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25486000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2037000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1807000
CY2018Q4 slno Disposal Group Including Discontinued Operation Deferred Tax Assets Liabilities Noncurrent
DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsLiabilitiesNoncurrent
15000
CY2017Q4 slno Disposal Group Including Discontinued Operation Deferred Tax Assets Liabilities Noncurrent
DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsLiabilitiesNoncurrent
17000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
67000
CY2018Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
425000
CY2017Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
459000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
70000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
36000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
542000
CY2018Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
31740000
CY2017Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
27950000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4062000
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4414000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4062000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4417000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23533000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27678000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23533000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4100000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
854000
CY2018 slno Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
23000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
87000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
964000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
795000
CY2017 slno Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
-4000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
63000
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2018Q4 slno Unrecognized Tax Benefits Offset By Valuation Allowance
UnrecognizedTaxBenefitsOffsetByValuationAllowance
964000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9514982
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9275399

Files In Submission

Name View Source Status
0001564590-19-008508-index-headers.html Edgar Link pending
0001564590-19-008508-index.html Edgar Link pending
0001564590-19-008508.txt Edgar Link pending
0001564590-19-008508-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slno-10k_20181231.htm Edgar Link pending
slno-20181231.xml Edgar Link completed
slno-20181231.xsd Edgar Link pending
slno-20181231_cal.xml Edgar Link unprocessable
slno-20181231_def.xml Edgar Link unprocessable
slno-20181231_lab.xml Edgar Link unprocessable
slno-20181231_pre.xml Edgar Link unprocessable
slno-ex211_10.htm Edgar Link pending
slno-ex231_11.htm Edgar Link pending
slno-ex311_9.htm Edgar Link pending
slno-ex312_8.htm Edgar Link pending
slno-ex321_7.htm Edgar Link pending
slno-ex322_6.htm Edgar Link pending